Team Prof. Dr. Ulf Kahlert
Leiter der Abteilung für Molekulare und Experimentelle Chirurgie
Director
Publications: www.scopus.com/authid/detail.uri?authorId=41661514600
Personal Webpage: www.mes.ulf-kahlert.com
ulf.kahlert@med.ovgu.deDirector
Publications: www.scopus.com/authid/detail.uri?authorId=41661514600
Personal Webpage: www.mes.ulf-kahlert.com
Wissenschaftlicher Mitarbeiter
Scientific assistance, regulatory and administrative affairs, ordering, management of
instrument suites
thomas.wartmann@med.ovgu.deScientific assistance, regulatory and administrative affairs, ordering, management of
instrument suites
Haupt-MTLA/Laborleitung
Head lab technician, quality control, head operator of the stem cell media reactor pipeline
claudia.blume@med.ovgu.deHead lab technician, quality control, head operator of the stem cell media reactor pipeline
Laborassistenz
Technical and organizational assistance for our clinically relevant research projects.
Technical and organizational assistance for our clinically relevant research projects.
Laborassistenz
Technical assistance is not just about preparing buffers and getting that n=3. It also means being there for the students, offering guidance and experimental experience, and finding solutions to technical problems.
christian.siba@med.ovgu.deTechnical assistance is not just about preparing buffers and getting that n=3. It also means being there for the students, offering guidance and experimental experience, and finding solutions to technical problems.
Postdoc/Postdoctoral Fellow
I conduct data mining to propose novel transcriptomic and epigenetic diagnostic and/or
therapeutic targets for cancer patients, for subsequent functional and mechanistic evaluation
in wet lab research in MES. I also analyze OMICS data retrieved from prospective clinical trials
of Magdeburg surgery patients and thereof derived-disease models.
wenjie.shi@med.ovgu.deI conduct data mining to propose novel transcriptomic and epigenetic diagnostic and/or
therapeutic targets for cancer patients, for subsequent functional and mechanistic evaluation
in wet lab research in MES. I also analyze OMICS data retrieved from prospective clinical trials
of Magdeburg surgery patients and thereof derived-disease models.
Wissenschaftlicher Mitarbeiter / Ph.D. candidate
I am investigating cancer recurrence mechanisms using a cancer stem cell-based liquid biopsy platform with CRISPR-Cas technology, as well as integrating in vivo and in vitro models under the 3R framework at the transcriptomic level. Additionally, I leverage my engineering background in the development and validation of medical devices and implants.
I am investigating cancer recurrence mechanisms using a cancer stem cell-based liquid biopsy platform with CRISPR-Cas technology, as well as integrating in vivo and in vitro models under the 3R framework at the transcriptomic level. Additionally, I leverage my engineering background in the development and validation of medical devices and implants.
Wissenschaftlicher Mitarbeiter/Ph. D Candidate
I am investigating cancer recurrence mechanisms using a cancer stem cell-based liquid
biopsy platform with CRISPR-Cas technology, as well as integrating in vivo and in vitro models under the 3R framework at the transcriptomic level. Additionally, I leverage my engineering background in the development and validation of medical devices and implants.
ahmed.sanin@med.ovgu.deI am investigating cancer recurrence mechanisms using a cancer stem cell-based liquid
biopsy platform with CRISPR-Cas technology, as well as integrating in vivo and in vitro models under the 3R framework at the transcriptomic level. Additionally, I leverage my engineering background in the development and validation of medical devices and implants.
Wissenschaftliche Mitarbeiterin / Ph.D. Candidate
I am a PhD student working on a co-culture model that combines colorectal cancer organoids with immune cells to better understand the interactions within the tumor microenvironment. This approach aims to uncover key mechanisms of immune evasion and tumor progression.
I am a PhD student working on a co-culture model that combines colorectal cancer organoids with immune cells to better understand the interactions within the tumor microenvironment. This approach aims to uncover key mechanisms of immune evasion and tumor progression.
Med. Doktorand / MD Candidate
Pancreatic tumors exhibit one of the lowest five-year survival rates among all cancer types. As a medical student, my research concentrates on the pathophysiology of pancreatic tumors. Specifically, I am investigating the significance of the protein BAMBI and specific miRNAs within the signaling pathways and metabolic mechanisms of pancreatic tumors. These components possess potential as diagnostic indicators and targets for therapeutic intervention.
paul.winter@st.ovgu.dePancreatic tumors exhibit one of the lowest five-year survival rates among all cancer types. As a medical student, my research concentrates on the pathophysiology of pancreatic tumors. Specifically, I am investigating the significance of the protein BAMBI and specific miRNAs within the signaling pathways and metabolic mechanisms of pancreatic tumors. These components possess potential as diagnostic indicators and targets for therapeutic intervention.
Medizinische Doktorandin / MD candidate
My research focuses on developing a rapid and standardized method for detecting miRNAs in the blood of pancreatic cancer patients. Specifically, I investigate the correlation of patient's miRNAs profile and occurrence or recurrence of the panceatic cancer.
My research focuses on developing a rapid and standardized method for detecting miRNAs in the blood of pancreatic cancer patients. Specifically, I investigate the correlation of patient's miRNAs profile and occurrence or recurrence of the panceatic cancer.
Med. Doktorand / MD Candidate
Considering the advances in minimal-invasive surgery, the question of the immunological
differences in the postoperative course based on the surgical approach
needs to be answered. Therefore, my research focuses on the inflammatory
reaction in patients undergoing laparoscopic/robotic-assisted or open liver surgery.
By investigating primary tissue and blood samples, I want to determine prognostic factors
for postoperative complications and patient outcome.
julia.nagelschmitz@st.ovgu.deConsidering the advances in minimal-invasive surgery, the question of the immunological
differences in the postoperative course based on the surgical approach
needs to be answered. Therefore, my research focuses on the inflammatory
reaction in patients undergoing laparoscopic/robotic-assisted or open liver surgery.
By investigating primary tissue and blood samples, I want to determine prognostic factors
for postoperative complications and patient outcome.
Med. Doktorand / MD Candidate
Neurological symptoms after surgical interventions are a problem many patients suffer from.
My research focuses on different surgical and anesthetic parameters to assess their
particular importance for neurological damage during and after the intervention.
I include especially the postoperative cognitive dysfunction and the critical illness
polyneuropathy/myopathy as a result of neurological damage.
levi.sochor@st.ovgu.deNeurological symptoms after surgical interventions are a problem many patients suffer from.
My research focuses on different surgical and anesthetic parameters to assess their
particular importance for neurological damage during and after the intervention.
I include especially the postoperative cognitive dysfunction and the critical illness
polyneuropathy/myopathy as a result of neurological damage.
Med. Doktorand (Vollzeit)
I am a medical student focusing on the pathophysiology of colorectal cancer (CRC). In
particular, I´m interested in the molecular marker collagen 10 (COLX), which promotes
invasiveness and aggressiveness of CRC by lateral information transfer and thus could
serve as a diagnostic marker as well as a therapeutic target.
marco.strecker@st.ovgu.deI am a medical student focusing on the pathophysiology of colorectal cancer (CRC). In
particular, I´m interested in the molecular marker collagen 10 (COLX), which promotes
invasiveness and aggressiveness of CRC by lateral information transfer and thus could
serve as a diagnostic marker as well as a therapeutic target.
Medizinische Doktorandin / MD candidate
Devoted to the research of digestive tract tumors, especially pancreatic cancer, I aim further to improve the early diagnosis rate of pancreatic cancer and promote individualized treatment of the disease through imaging and genetic research.
Devoted to the research of digestive tract tumors, especially pancreatic cancer, I aim further to improve the early diagnosis rate of pancreatic cancer and promote individualized treatment of the disease through imaging and genetic research.
Medizinischer Doktorand / MD Candidate
My study is centered on examining the micro-mechanical properties of pancreatic cancer cells and their organoids, with a focus on parameters such as elastic modulus and stiffness. Furthermore, I aim to elucidate the signaling pathways that regulate the mechanical properties of pancreatic cancer cells, thereby establishing a theoretical basis for the discovery of potential therapeutic targets.
My study is centered on examining the micro-mechanical properties of pancreatic cancer cells and their organoids, with a focus on parameters such as elastic modulus and stiffness. Furthermore, I aim to elucidate the signaling pathways that regulate the mechanical properties of pancreatic cancer cells, thereby establishing a theoretical basis for the discovery of potential therapeutic targets.
As a master's student, I investigate the therapeutic potential of taurine in the treatment of colon cancer, focusing on its effects on cancer cell growth and viability. I also study and characterize circulating tumor cells (CTCs) to further our understanding of cancer metastasis and progression.